In this study, we confirmed through in vitro and vivo experiments using WB and qPCR that ZGW significantly regulates the expression of key proteins such as TP53, NF-κB, and PKC, providing molecular evidence for its role in treating OAS. Here, NFKB1 is linked to microphthalmia with limb anomalies.